APA (7th ed.) Citation

Wang, Q., Yang, J., Wang, Y., Liu, H., Feng, Y., Qiu, L., & Chen, Y. (2023). Lutetium177-Labeled DOTA-Ibandronate. Molecular Pharmaceutics, 20(3), 1788-1795. https://doi.org/10.1021/acs.molpharmaceut.2c00978

Chicago Style (17th ed.) Citation

Wang, Qixin, Jian Yang, Yingwei Wang, Hanxiang Liu, Yue Feng, Lin Qiu, and Yue Chen. "Lutetium177-Labeled DOTA-Ibandronate." Molecular Pharmaceutics 20, no. 3 (2023): 1788-1795. https://doi.org/10.1021/acs.molpharmaceut.2c00978.

MLA (9th ed.) Citation

Wang, Qixin, et al. "Lutetium177-Labeled DOTA-Ibandronate." Molecular Pharmaceutics, vol. 20, no. 3, 2023, pp. 1788-1795, https://doi.org/10.1021/acs.molpharmaceut.2c00978.